Eric William

Professor

Western University

Canada

Research Interests

Explore related searches

Professors in Canada

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Eric William is a faculty member at Western University, located in Canada. His research primarily focuses on oncology, with recent articles exploring innovative treatments for metastatic prostate cancer, rare cancers, and thyroid cancer management. In addition, he has contributed to studies on the utilization of novel therapies and biomarkers in cancer treatment.

Articles (10)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (7)

Aaron R. Hansen

University Health Network

CANADA

View details

Kim Chi

Chief Medical Officer

BC Cancer

CANADA

View details

Theodorus van der Kwast

CANADA

View details

Di Maria Jiang

University Health Network

CANADA

View details

Omar M Abdel-Rahman Abdelsalam

Associate Professor

University of Alberta

CANADA

View details

Kasmintan Schrader

The University of British Columbia

CANADA

View details

Sebastien Hotte

McMaster University

CANADA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Eric William

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Randomized Phase II Study of Durvalumab with or without Tremelimumab in Patients with Metastatic Castration-Resistant Prostate Cancer

Durvalumab and tremelimumab in patients with advanced rare cancer: a multi-centre, non-blinded, open-label phase II basket trial

Consensus Statement: Recommendations on Actionable Biomarker Testing for Thyroid Cancer Management

Correction: Consensus Statement: Recommendations on Actionable Biomarker Testing for Thyroid Cancer Management

Clinical Outcome Patterns of Use of Radium-223 in Patients with Metastatic Castration-Resistant Prostate Cancer

The Use of Salvage Chemotherapy for Patients with Relapsed Testicular Germ Cell Tumor (GCT) in Canada: A National Survey

Neoadjuvant Cabazitaxel plus Abiraterone/Leuprolide Acetate in Patients with High-Risk Prostate Cancer: ACDC-RP Phase II Trial

Phase 4 Multinational Multicenter Retrospective and Prospective Real-World Study of Nivolumab in Recurrent and Metastatic Squamous Cell Carcinoma of the Head and Neck

Duloxetine for prevention and treatment of chemotherapy-induced peripheral neuropathy (CIPN): systematic review and meta-analysis

Metabolomic identification of predictive and early biomarkers of cisplatin-induced acute kidney injury in adult head and neck cancer patients

Collaborators (7)

Aaron R. Hansen

Kim Chi

Theodorus van der Kwast

Di Maria Jiang

Omar M Abdel-Rahman Abdelsalam

Kasmintan Schrader

Sebastien Hotte

Make your next move.